Rossi, G.; Borlenghi, E.; Zappasodi, P.; Lussana, F.; Bernardi, M.; Basilico, C.; Molteni, A.; Lotesoriere, I.; Turrini, M.; Frigeni, M.;
et al. Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers 2024, 16, 386.
https://doi.org/10.3390/cancers16020386
AMA Style
Rossi G, Borlenghi E, Zappasodi P, Lussana F, Bernardi M, Basilico C, Molteni A, Lotesoriere I, Turrini M, Frigeni M,
et al. Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers. 2024; 16(2):386.
https://doi.org/10.3390/cancers16020386
Chicago/Turabian Style
Rossi, Giuseppe, Erika Borlenghi, Patrizia Zappasodi, Federico Lussana, Massimo Bernardi, Claudia Basilico, Alfredo Molteni, Ivana Lotesoriere, Mauro Turrini, Marco Frigeni,
and et al. 2024. "Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda" Cancers 16, no. 2: 386.
https://doi.org/10.3390/cancers16020386
APA Style
Rossi, G., Borlenghi, E., Zappasodi, P., Lussana, F., Bernardi, M., Basilico, C., Molteni, A., Lotesoriere, I., Turrini, M., Frigeni, M., Fumagalli, M., Cozzi, P., Gigli, F., Cattaneo, C., Fracchiolla, N. S., Riva, M., Martini, G., Mancini, V., Cairoli, R.,
& Todisco, E.
(2024). Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers, 16(2), 386.
https://doi.org/10.3390/cancers16020386
